Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 1006-1015

  Pasero, Giampiero ^a   Priolo, Francesco ^b   Marubini, Ettore ^c   Fantini, Flavio ^c   Ferraccioli, Gianfranco ^d   Magaro, Mario ^b   Marcolongo, Roberto ^e   Oriente, Pasquale ^f   Pipitone, Vincenzo ^g   Portioli, Italo ^h   Tirri, Giuseppe ^f   Trotta, Francesco ⁱ   Della Casa Alberighi, Ornella ^j  

^a UNIVERSITY OF PISA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ S ANNA HOSPITAL   (Italy)

^j Sandoz PF   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOMALATE; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN A; GOLD SALT; HYDROXYCHLOROQUINE SULFATE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE; THIOL DERIVATIVE; TIOPRONIN;

ADULT; AGED; ARTHROPATHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; CREATININE; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 8944256867     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390618     Document Type: Article

References (53)

1. Sharp JT: Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 32:221-229, 1989
2. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T: Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585-591, 1989
3. Iannuzzi L, Dawson N, Zein N, Kushner I: Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 309:1023-1028, 1983
4. Alarcón GS, López-Méndez A, Walter J, Boerbooms AMT, Russel AS, Walter J, Furst DE, Rau R, Drosos AA, Bartolucci AA: Radiographic evidence of disease modifying antirheumatic drugs tested in rheumatoid arthritis patients: a meta-analysis. J Rheumatol 19: 1868-1873, 1992
5. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990
6. Wilske KR, Healey LA: Remodelling the pyramid - a concept whose time has come. J Rheumatol 16:565-567, 1989
7. Furst DE: Should methotrexate be used to treat early rheumatoid arthritis? Semin Arthritis Rheum 23 (suppl 2):39-43, 1994
8. Wilke WS, Sweeney TJ, Calabrese LH: Models of combination therapy with disease modifying antirheumatic drugs: early, aggressive therapy for rheumatoid arthritis: concerns, descriptions and estimate of outcome. Semin Arthritis Rheum 23 (suppl 1):26-41, 1994
9. Kingsley GH, Panayi GS, Lanchbury JSS: Immunotherapy of rheumatic diseases: practice and prospects. Immunol Today 12: 177-179, 1991
10. Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Hermans J, Montnor-Beckers ZL, Jacobs PC, Cats A: Cyclosporine treatment for rheumatoid arthritis: a placebo controlled double-blind multicentre study. Ann Rheum Dis 45:726-731, 1986
11. Førre Ø, Bjerkhoel F, Salvesen CF, Berg KJ, Rugstad HE, Saelid G, Mellbye OJ, Kåss E: An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 30:88-92, 1987
12. Dougados M, Awada H, Amor B: Cyclosporine in rheumatoid arthritis: a double-blind, placebo-controlled study in 52 patients. Ann Rheum Dis 47:127-133, 1988
13. Yocum DE, Klippel JH, Wilder RL, Gerber NL, Austin HA, Wahl SM, Lesko L, Minor JR, Preuss HG, Yarboro C, Berkebile C, Dougherty S: Cyclosporin A in severe treatment of refractory rheumatoid arthritis. Ann Intern Med 109:863-869, 1988
14. Dougados M, Luchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis. Ann Rheum Dis 48:550-556, 1989
15. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR. Ludwin D, Roberts R: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 335:1051-1055, 1990
16. Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, Boers M, Cats A: Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized double-blind study. J Rheumatol 18:815-820, 1991
17. Landewé RBM, Goei Thè HS, van Rijthoven AWAM, Breedveld FC, Dijkmans BAC: A randomized double-blind 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 37:637-643, 1994
18. An International Consensus Report: The use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 32 (suppl 1):1-3, 1993
19. Førre Ø and the Norwegian Arthritis Study Group: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 37:1506-1512, 1994
20. Paulus HE, Bulpitt KJ: DC-ART classification: review of relevant clinical studies. J Rheumatol 21 (suppl 41):8-22, 1994
21. Pincus T: Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 41:1037-1041, 1988
22. Sharp JT, Wolfe F, Corbett M, Isomaki H, Mitchell DM, Furst DE, Sibley J, Shipley M: Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification? Ann Rheum Dis 52:332-337, 1993
23. Brook A, Corbett M: Radiographic changes in early rheumatoid disease. Ann Rheum Dis 36:71-73, 1977
24. Larsen A, Thoen J: Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 16:395-401, 1987
25. Möttönen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653, 1988
26. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van't Hof MA, van Rijswijk M, van de Putte LBA: Biannual radiographic assessment of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 35:26-34, 1992
27. Salaffi F, Ferraccioli GF: Progress of the anatomical damage in rheumatoid hands: radiography of the natural course of the disease or of the course during treatment? Scand J Rheumatol 18:119-120, 1989
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
29. Pasero G, Pellegrini P, Ambanelli U, Ciompi ML, Colamussi V, Ferraccioli G, Barbieri P, Mazzoni MR, Menegale G, Trippi D: Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis Rheum 25:923-929, 1982
30. Holt DW, Johnston A, Roberts NB, Tredger JM, Trull AK: Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force. Ann Clin Biochem 31:420-446, 1994
31. Huskisson EC: Measurement of pain. J Rheumatol 5:768-769, 1982
32. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 147:393-406, 1968
33. Lee P, Webb J, Anderson JA, Buchanan WW: A method for assessing the therapeutic potential of anti-inflammatory, antirheumatic drugs in rheumatoid arthritis. BMJ 2:685-688, 1973
34. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
35. Ferraccioli GF: Radiographic assessment of rheumatoid arthritis: controversies and perspective. Clin Exp Rheumatol 8:529-530, 1990
36. Larsen A, Dale K, Eek M, Pahle J: Radiographic evaluation of rheumatoid arthritis by standard reference films. J Hand Surg 8:667-669, 1983
37. Gillings D, Koch G: The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Inform J 25:411-424, 1991
38. Marubini E, Valsecchi MG: Analysing survival data from clinical trials and observational studies. In, Wiley Statistics in Practice Series. Chichester, UK, J Wiley & Sons, 1995
39. Scott DL, Coulton BL, Bacon PA, Popert AJ: Methods of x-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol 24:31-39, 1985
40. Scott DL, Adebajo AO, El Badaway S, Kirwan J, van de Putte LBA, van Riel PLCM: DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage. J Rheumatol 21 (suppl 41):36-40, 1994
41. Tunn EJ, Bacon PA: Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32:97-103, 1993
42. Sharp JT, Wolfe F, Mitchell DM, Bloch DA: The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 34:660-668, 1991
43. Jeurissen MEC, Boerbooms AMTh, van de Putte L, Doesburg WH, Lemmens AM: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. Ann Intern Med 114:999-1004, 1991
44. Herbon G, Rau R, Menninger H, Ezhardt D, Schmitt J: Data of two years of the comparative study of methotrexate/aurothiomalate in 102 patients. Z Rheumatol 51:163-171, 1992
45. Tugwell P: Cyclosporine in the treatment of rheumatoid arthritis. J Autoimmun 5 (suppl A):231-240, 1992
46. Torley H, Yocum D: Effects of dose and treatment duration on adverse experiences with cyclosporine in RA: analysis of North American trials (abstract). Arthritis Rheum 37 (suppl 9):S334, 1994
47. Landewe RBM, Goei The HS, van Rijthoven AWAM, Rietveld JR, Breedveld FC, Dijkmans BAC: Cyclosporin in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis. J Rheumatol 21:1631-1636, 1994
48. R) in Autoimmune Diseases: renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. Br J Rheumatol 32 (suppl 1):65-71, 1993
49. Feutren G, Mihatsch MJ, for the International Kidney Biopsy Registry of Cyclosporin In Autoimmune Diseases: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
50. Van der Heijde DMFM, van Riel PLCM, van Rijsnijk MH, van de Putte LBA: Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 17:284-292, 1988
51. Dawes PT: Radiological assessment of outcome in rheumatoid arthritis. Br J Rheumatol 27 (suppl 1):21-36, 1988
52. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ: Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 110:259-266, 1989
53. Kurki P: Cyclosporin A in rheumatoid arthritis: future perspectives. Br J Rheumatol 32 (suppl 1):76-78, 1993